During the past decade three types of antipoliomyelitie sera have been employed in the therapy of acute anterior poliomyelitis. These are, first, the sera of convalescent human poliomyelitis; second, sera from horses immunized against the streptococci supposed by Rosenow and others (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) to be etiologically related to poliomyelitis; third, the Pettit serum prepared at the Pasteur Institute (13) . The last mentioned product consists of sheep serum or horse serum from animals supposedly immunized against poliomyelitis virus through repeated intravenous injections of emulsions of spinal cords of poliomyelitic monkeys. The experimental evidence upon which Rosenow and his coworkers base their claims for the efficacy of anfistreptococcus poliomyelitis serum is discussed in another paper (14) and need not receive further mention at this moment. As regards the antipoliomyelitic serum of Pettit, it is sufficient to say that, so far as can be determined, the experimental evidence for its therapeutic value rests upon a single neutralization experiment of somewhat doubtful significance, as we shall later show. Since both the Rosenow and Pettit's serums have been more or less widely employed, it was deemed desirable to study this neutralizing action on the virus of poliomyelitis. Amoss and Eberson (20) have already made a series of neutralizing tests with the Rosenow serum and failed to detect neutralizing properties. The Pettit serumwas originally prepared from sheep'"immunized" by intravenous injection with suspensions of poliomyelitic monkey cords. Later, "immune" horse serum was produced by a similar procedure (15) . As previously mentioned, only one neutralization experiment is recorded. Two monkeys, A and B, received intracerebraUy virus plus "immune" sheep serum and virus alone respectively. The monkey with the serum-virus mixture remained normal, but the monkey receiving virus 449 alone developed typical poliomyelitis. Since occasional neutralization of poliomyelitis virus by sheep sera is not at all unknown in this laboratory (21), we were inclined to suspect that the apparent favorable result obtained by Pettit rested upon some such chance neutralization; this was more probable since in the experiment reported the control neutralization set up was made with virus alone instead of with a mixture of virus plus "normal" sheep serum. This is an unsafe procedure in testing a heterologous serum. For this occasional virus neutralization by sera of non-susceptible animals, no immediate explanation is apparent. Numerous clinical papers (15) (16) (17) (18) (19) are available, showing the supposed beneficial effect of the Pettit serum in the arrest of human poliomyelitis. In none is it possible for an unbiased reader to ascertain any certain evidence that the beneficial results attained were really due to the serum therapy. In fact, certain favorable results are claimed in late paralyzed cases well beyond the period of acute disease and even in ~ases of myelitis certainly clinically of non-poliomyelitic variety.
T h e e x p e r i m e n t s to be r e p o r t e d in t h e p r e s e n t p a p e r are several. All were rigorously controlled.
Macacus rhesus monkeys were used as experimental animals. The poliomyelitis virus serving for infection was the Rockefeller Institute M.A. strain. The Rosenow serum was obtained from Eli Lilly and Company, the Pettit serum through the kindness of Dr. A. Pettit; a similar serum was later prepared by us in accordance with Pettit's original published method. As control sera we employed those of convalescent humans, convalescent monkeys, normal monkeys, normal horse, and normal sheep. The sera to be tested were mixed with either suspensions or Berkefeld filtrates of fresh virus, were incubated 2 hours, and allowed to stand overnight in the ice box. All animals were etherized and infected Tables I to VI . We are concemed only with the development of definite paralytic poliomyelitis and not with the question of death or survival, degree of paralyses, or length of incubation periods. In small series these are deemed of doubtful significance.
I t is e v i d e n t from the three series of e x p e r i m e n t s s u m m a r i z e d in T a b l e s I to I I I t h a t no v i r u s n e u t r a l i z a t i o n s h a v e occurred with Rosen o w ' s s e r u m --a t least with the three different samples employed.
T h e P e t t i t s e r u m has n e u t r a l i z e d , b u t the n e u t r a l i z a t i o n was inc o n s t a n t . T o test f u r t h e r this serum, the virus used was p r e p a r e d as a s u s p e n s i o n r a t h e r t h a n a B e r k e f e l d f i l t r a t e . P e t t i t u t i l i z e d s u s p e nsions i n his o w n n e u t r a l i z a t i o n t e s t s .
F u r t h e r r e s u l t s w i t h b o t h susp e n s i o n a n d f i l t r a t e a p p e a r in T a b l e I V . I t is q u i t e a p p a r e n t t h a t t h e P e t t i t s e r u m d o e s n o t c o n s i s t e n t l y n e u t r a l i z e v i r u s . Following these experiments, we determined to prepare sheep sera according to the method of PettAt. Three sheep were used. Previous to the first inoculation, the sera of these animals were tested for virus neutralization in monkeys. The results appear in Table V Thus it would appear that Sheep I serum, previous to any immunization, inhibited Berkefeld filtrate once and at another time failed to inhibit suspension; that Sheep II serum /ailed to inhibit Berkefeld filtrate; that Sheep III serum inhibited Berkefeld filtrate. Sheep I was lost from intercurrent disease. Sheep II and III were given twenty-one biweekly, intravenous injections, each consisting of 5 cc. of 5 per cent virus suspension from fresh or glycerolated monkey spinal cords. The animals were bled after a brief rest, and the sera were again tested for neutralization or inhibition.
The lack of consistency in results is well shown by the fact that both normal sera inhibited or neutralized virus, whereas sera from the same animals after "immunization" failed to do so.
CONCLUSIONS.
1. The Rosenow antistreptococcic poliomyelitis serum concentrated or unconcentrated does not neutralize the virus of poliomyelitis as tested in monkeys.
2. The Pettit antipoliomyelitis horse serum neutralizes the virus only occasionally.
3. "Immune" sheep sera prepared according to the method of Pettit have not neutralized virus even when the normal sera of the same animal have given neutralization.
4. The reason for such chance neutralizations is obscure and should not be confused with the constant virus-neutralizing action of both human and monkey convalescent sera.
5. Experimental evidence affords no basis for the use of either the Rosenow or the Pettit serum in the therapy of poliomyelitis.
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